Sterilant Vapor Generation With MME for Diffusion-Restricted Devices

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing sterilization methods face challenges in effectively sterilizing medical devices, particularly those with diffusion-restricted areas, due to the instability and reactivity of peroxy acids like performic acid, which require immediate use and pose handling hazards, and the need for improved methods to enhance sterilization efficiency and safety.

Innovation Solution

A vacuum-based sterilization system using a peri-peroxy acid solution combined with a molecular mobility enhancer (MME) to enhance vaporization and transport of peroxy acid vapor, allowing for faster and more effective sterilization of medical devices, including those with intricate structures.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If peroxy acid (performic acid) is used as sterilant, then sterilization effectiveness is improved, but stability and handling safety deteriorate

Engineering Contradiction:
Improvesterilization effectivenessVSAvoidperoxy acid stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The system pre-generates performic acid vapor in a separate generation chamber before introducing it to the sterilization chamber. This preliminary action allows the unstable peroxy acid to be created and immediately utilized without requiring storage or handling of the unstable liquid form, resolving the contradiction between effectiveness and stability

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent introduces a molecular mobility enhancer (MME) as an intermediary substance that facilitates the vaporization and transport of performic acid. The MME mediates between the unstable peroxy acid and the sterilization environment, enabling effective sterilization while maintaining safety through controlled vapor generation

Inventive Principle:
Principle #24Intermediary (Mediator)

2Object-affected harmful factors

If conventional sterilization methods are used, then handling safety is improved, but sterilization effectiveness for diffusion-restricted areas deteriorates

Engineering Contradiction:
Improvehandling safetyVSAvoidsterilization effectiveness
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent replaces mechanical/physical sterilization methods with a chemical vapor sterilization system. Performic acid vapor, generated and transported with enhanced mobility, effectively penetrates diffusion-restricted areas where conventional mechanical methods fail, while maintaining handling safety through automated vapor generation

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The system changes the physical state of the sterilant from liquid to vapor phase, and controls parameters such as vapor concentration, temperature, and pressure to optimize penetration into diffusion-restricted areas. This parameter transformation enables effective sterilization of complex geometries while maintaining safety

Inventive Principle:
Principle #35Parameter changes

3Productivity

If vacuum-based sterilization with MME is used, then sterilization speed is improved, but system complexity increases

Engineering Contradiction:
Improvesterilization speedVSAvoidsystem complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The sterilization system is segmented into distinct functional modules: a vapor generation chamber for creating performic acid vapor, a transfer system for moving the vapor, and a sterilization chamber for the actual treatment. This segmentation enables faster sterilization cycles while managing complexity through modular design

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The molecular mobility enhancer serves as an intermediary that accelerates vaporization and transport processes. By introducing this chemical mediator, the system achieves faster sterilization speeds without requiring proportionally complex mechanical systems, as the MME naturally enhances molecular movement

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system achieves enhanced sterilization with a desired SAL of 10−6 in a shorter time, overcoming the limitations of peroxy acid stability and handling hazards, while ensuring thorough sterilization of medical devices.

Implementation Method 1

enhances the vaporization and mobility of hydrogen peroxide or a peroxy acid, such as performic acid, under reduced pressure and low temperatures

Methodology Applied
Scientific EffectVaporization: Evaporation

Implementation Method 2

enhances the vaporization and mobility of hydrogen peroxide or a peroxy acid, such as performic acid, under reduced pressure and low temperatures to provide enhanced or improved sterilization

Methodology Applied
Scientific EffectDiffusion: Diffusion

Implementation Method 3

A vacuum-based sterilization system using a peri-peroxy acid solution combined with a molecular mobility enhancer (MME) to enhance vaporization and transport of peroxy acid vapor

Methodology Applied
Scientific EffectVacuum: Vacuum

Data Source

PatentUS20250375548A1Sterilization process, system and product including molecular mobility enhancer
Publication Date: 2025.12.11 TEKDRY INT
  • US20250375548A1 patent drawing
  • US20250375548A1 patent drawing
  • US20250375548A1 patent drawing

AI summary

Methods for generating a sterilant vapor in a sub-atmospheric environment for use in sanitization and sterilization. The vapor is generated from a mixture containing a sterilant and a molecular mobility enhancer (MME). More specifically, the use of the MME enhances the vaporization and mobility of the sterilant, particularly hydrogen peroxide and/or a peroxy acid, to provide enhanced or improved sterilization. Also provided are solid-form sterilant comprising a sterilant and an MME. Further provides are various packaged forms of sterilant, particularly containing hydrogen peroxide and/or a peroxy acid for use in sanitation and sterilization methods herein.